{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-271405","form_type":"8-K","ticker":"RMD","cik":"0000943819","company_name":"RESMED INC","filed_at":"2021-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:04:21.348548+00:00","generated_at":"2026-06-29T04:24:33.835064+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"ResMed amends bylaws to reduce special meeting threshold from majority to 20%","bullets":["Board approved seventh amended and restated bylaws effective September 10, 2021.","Special meetings now callable by holders of at least 20% of outstanding shares (previously majority).","Amendment lowers the barrier for shareholders to call special meetings."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-271405","json":"https://secwatch.observer/filing/0001193125-21-271405.json","markdown":"https://secwatch.observer/filing/0001193125-21-271405.md","text":"https://secwatch.observer/filing/0001193125-21-271405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/943819/000119312521271405/0001193125-21-271405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/943819/000119312521271405/d215540d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T04:24:33.835064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}